Updates in Retina Treatment (Test Episode)

• (00:00) - Intro
• (00:31) - Faculty Introductions
• (00:47) - Unnecessary Chapter Explanation
• (01:03) - No Content to Present
• (01:27) - Awkward Laugh
• (01:34) - Outro
• (00:00) - Chapter 7
• (00:00) - Chapter 8

If you haven't already, please CLICK HERE prior to listening to view the CME information and gain credit for this activity.

Activity description
Treatment approaches for retinal vascular disease are evolving with the introduction of second-generation therapies such as faricimab and high-dose aflibercept (8 mg). What could these changes mean for your clinical practice? Join leading experts as they explore their real-world experiences with these emerging options and dive into key innovations, common challenges, and practical strategies—including OCT monitoring, biomarker utilization, and effective patient engagement—in this dynamic and insightful podcast activity.  

When you are finished listening please click here to complete the evaluation and request credit

REFERENCES

RESOURCES

What is Archetype Clinical Correspondence - Retina Test Podcast?

Retina Test Podcast is a medical education podcast designed specifically for retina specialists. Each episode features expert faculty who delve into timely and clinically relevant topics in the field of retina care. With engaging discussions and evidence-based insights, the podcast serves as a convenient and valuable resource for continuous professional development. Listeners can earn CME credit with every episode, making it an essential tool for staying current with advancements in retinal medicine while fulfilling ongoing education requirements.

To receive CME for listening to an episode, please visit https://archetype-clinical.transistor.fm/

Rob: 00:00

You are listening to the Retina Test Podcast brought to you by Archetype Clinical Correspondence. The Retina Test Podcast is a CME Certified educational activity that provides in-depth clinical conversations about the latest treatment in neovascular retinal disease from experts in the field. To view CME information and to obtain credit, please visit the link in the show notes. Thank you for listening. Welcome to the Retina Test Podcast.

Rob: 00:32

This is a test and not an actual episode. This is where the faculty would begin speaking, and they'd be introducing themselves. And I'm speaking right now so that we can get some voice over to test the transcripts as as well as testing the chapter features. Now the chapters would probably go as such, they'd probably start at the very beginning with chapter one. Chapter two would likely begin when the faculty start talking and introducing themselves.

Rob: 00:57

And chapter three, beginning with the actual content. Now I don't have any actual content to present right now, and so I'm just gonna kinda keep talking here for a little bit so that we can get, again like I said, some more voice over so that we can test the transcript and the chapter features on Transistor. I didn't really write anything to say, and so I'm just sort of vamping right now, and I don't don't know all that much about neovascular retinal disease. So that's probably enough now. Thank you for listening to the Retina Test Podcast from Archetype Clinical Correspondence.

Rob: 01:38

To attain CME credit for the episode you just listened to, please visit the link in the show notes.